Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

Register using your

PHARMACEUTICALS COMPANIES back to topic

Hualan Biological Engineering’s vaccine performance declined in 2011H1, blood product business expected to be favorable -ResearchInChina

researchinchina.com. Added by Chen Li on September 25, 2011

report

save

This article has:

Reactions to Hualan Biological Engineering’s vaccine performance declined in 2011H1, blood product business expected to be favorable -ResearchInChina

Date

Type Channel Author

Search Cancel